Citius Oncology Inc. has announced a private placement involving the sale of shares of its common stock, pre-funded warrants, and warrants to a single healthcare-focused investor. These securities, along with unregistered warrants to purchase additional shares, are being offered in a private placement under Section 4(a)(2) of the Securities Act and/or Regulation D. The shares and warrants sold in the private placement have not been registered under the Securities Act or state securities laws and can only be resold under an effective registration statement or an applicable exemption. The company has agreed to file a registration statement with the SEC to cover the resale of these securities.